STOCK TITAN

[Form 4] Walgreens Boots Alliance, Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Manmohan Mahajan, EVP and Global CFO of Walgreens Boots Alliance (WBA), reported a transaction dated 08/28/2025 disposing of 414,273 shares of WBA common stock, leaving him with 0 shares beneficially owned following the transaction. The Form 4 explains the disposition resulted from the Merger under the March 6, 2025 Merger Agreement, where each share was converted at the Effective Time into $11.45 in cash plus one Divested Asset Proceed Right. RSUs held by the reporting person were cancelled in exchange for the Per Share Consideration, although any unvested RSUs remain subject to the original vesting conditions tied to continued service.

Manmohan Mahajan, EVP e Chief Financial Officer globale di Walgreens Boots Alliance (WBA), ha segnalato una transazione del 28/08/2025 con la cessione di 414.273 azioni ordinarie WBA, rimanendo con 0 azioni possedute dopo l’operazione. Nel Modulo 4 si precisa che la cessione è derivata dalla Fusione prevista dal Contratto di Fusione del 6 marzo 2025: a ogni azione, al momento dell’Effetto, è stato corrisposto $11,45 in contanti più un Divested Asset Proceed Right. Le RSU detenute dal dichiarante sono state annullate in cambio del Corrispettivo per Azione; le RSU non ancora maturate restano comunque soggette alle condizioni di vesting originarie legate alla continuazione del rapporto di servizio.

Manmohan Mahajan, EVP y Director Financiero Global de Walgreens Boots Alliance (WBA), informó una operación fechada el 28/08/2025 en la que dispuso de 414.273 acciones ordinarias de WBA, quedando con 0 acciones tras la transacción. El Formulario 4 explica que la enajenación provino de la Fusión conforme al Acuerdo de Fusión del 6 de marzo de 2025; en el Momento de Efectividad, cada acción se convirtió en $11,45 en efectivo más un Divested Asset Proceed Right. Las RSU en posesión del declarante se cancelaron a cambio de la Compensación por Acción; las RSU no adquiridas siguen sujetas a las condiciones de adquisición originales vinculadas a la continuidad del servicio.

Manmohan Mahajan, Walgreens Boots Alliance(WBA)의 EVP 겸 글로벌 최고재무책임자(CFO)는 2025년 8월 28일자로 WBA 보통주 414,273주를 처분한 거래를 신고했으며, 거래 후 보유 지분은 0주입니다. Form 4에는 해당 처분이 2025년 3월 6일 체결된 합병계약에 따른 합병 결과라고 명시되어 있으며, 효력 발생 시 각 주식은 $11.45의 현금1개의 Divested Asset Proceed Right로 전환되었습니다. 신고인의 RSU는 주당 대가로 대체되어 취소되었고, 단 미확정 RSU는 계속 근무 조건에 따른 원래의 가속(vesting) 조건이 계속 적용됩니다.

Manmohan Mahajan, EVP et Directeur financier mondial de Walgreens Boots Alliance (WBA), a déclaré une opération datée du 28/08/2025 portant sur la cession de 414 273 actions ordinaires WBA, ne détenant plus aucune action après la transaction. Le formulaire 4 précise que la cession résulte de la Fusion en vertu de l’Accord de Fusion du 6 mars 2025 : à la Date d’Effet, chaque action a été convertie en 11,45 $ en numéraire plus un Divested Asset Proceed Right. Les RSU détenues par le déclarant ont été annulées en échange de la contrepartie par action ; les RSU non acquises restent néanmoins soumises aux conditions de vesting originales liées à la poursuite du service.

Manmohan Mahajan, EVP und Global CFO von Walgreens Boots Alliance (WBA), meldete eine Transaktion vom 28.08.2025, bei der er 414.273 Aktien der WBA-Stammaktien veräußerte und nach der Transaktion 0 Aktien besitzt. Im Formular 4 wird erläutert, dass die Veräußerung aus der Verschmelzung gemäß dem Fusionsvertrag vom 6. März 2025 resultierte: Zum Zeitpunkt des Wirksamwerdens wurde jede Aktie in $11,45 in bar zuzüglich eines Divested Asset Proceed Right umgewandelt. Die vom Meldenden gehaltenen RSUs wurden im Austausch gegen die Vergütung pro Aktie annulliert; nicht unverfallte RSUs unterliegen weiterhin den ursprünglichen Vesting-Bedingungen, die an die fortgesetzte Dienstzeit geknüpft sind.

Positive
  • Per-share cash consideration of $11.45 was provided to the reporting person as part of the merger, ensuring cash realization for each converted share
  • RSUs converted into Per Share Consideration, and unvested RSUs remain subject to original vesting, preserving compensation structure continuity
Negative
  • Reporting person beneficial ownership reduced to 0 shares following the reported transaction
  • Cancellation of RSUs means equity stake in the public company was eliminated at the Effective Time

Insights

TL;DR: Insider ownership reduced to zero due to merger consideration, with RSUs converted and unvested units still subject to service-based vesting.

The Form 4 documents a disposition of 414,273 shares by the EVP/CFO that is solely attributable to the corporate merger transaction. From a governance perspective, the disclosure is straightforward and consistent with merger mechanics: common stock and RSUs were converted into merger consideration rather than sold on the open market. The filing clarifies treatment of unvested RSUs, which preserves customary employment-based vesting obligations. This reduces public insider alignment but reflects deal terms rather than voluntary insider selling.

TL;DR: Disposition reflects merger consideration mechanics: per-share cash of $11.45 plus a divested-asset right; RSUs converted per the Merger Agreement.

The transaction arises from the Merger Agreement dated March 6, 2025, effective at the merger closing. Each common share converted into $11.45 cash and one Divested Asset Proceed Right, and RSUs were cancelled for the same Per Share Consideration with unvested units retaining service-based vesting. This filing documents the expected conversion of equity instruments under merger terms and explains post-closing treatment of equity awards for senior management.

Manmohan Mahajan, EVP e Chief Financial Officer globale di Walgreens Boots Alliance (WBA), ha segnalato una transazione del 28/08/2025 con la cessione di 414.273 azioni ordinarie WBA, rimanendo con 0 azioni possedute dopo l’operazione. Nel Modulo 4 si precisa che la cessione è derivata dalla Fusione prevista dal Contratto di Fusione del 6 marzo 2025: a ogni azione, al momento dell’Effetto, è stato corrisposto $11,45 in contanti più un Divested Asset Proceed Right. Le RSU detenute dal dichiarante sono state annullate in cambio del Corrispettivo per Azione; le RSU non ancora maturate restano comunque soggette alle condizioni di vesting originarie legate alla continuazione del rapporto di servizio.

Manmohan Mahajan, EVP y Director Financiero Global de Walgreens Boots Alliance (WBA), informó una operación fechada el 28/08/2025 en la que dispuso de 414.273 acciones ordinarias de WBA, quedando con 0 acciones tras la transacción. El Formulario 4 explica que la enajenación provino de la Fusión conforme al Acuerdo de Fusión del 6 de marzo de 2025; en el Momento de Efectividad, cada acción se convirtió en $11,45 en efectivo más un Divested Asset Proceed Right. Las RSU en posesión del declarante se cancelaron a cambio de la Compensación por Acción; las RSU no adquiridas siguen sujetas a las condiciones de adquisición originales vinculadas a la continuidad del servicio.

Manmohan Mahajan, Walgreens Boots Alliance(WBA)의 EVP 겸 글로벌 최고재무책임자(CFO)는 2025년 8월 28일자로 WBA 보통주 414,273주를 처분한 거래를 신고했으며, 거래 후 보유 지분은 0주입니다. Form 4에는 해당 처분이 2025년 3월 6일 체결된 합병계약에 따른 합병 결과라고 명시되어 있으며, 효력 발생 시 각 주식은 $11.45의 현금1개의 Divested Asset Proceed Right로 전환되었습니다. 신고인의 RSU는 주당 대가로 대체되어 취소되었고, 단 미확정 RSU는 계속 근무 조건에 따른 원래의 가속(vesting) 조건이 계속 적용됩니다.

Manmohan Mahajan, EVP et Directeur financier mondial de Walgreens Boots Alliance (WBA), a déclaré une opération datée du 28/08/2025 portant sur la cession de 414 273 actions ordinaires WBA, ne détenant plus aucune action après la transaction. Le formulaire 4 précise que la cession résulte de la Fusion en vertu de l’Accord de Fusion du 6 mars 2025 : à la Date d’Effet, chaque action a été convertie en 11,45 $ en numéraire plus un Divested Asset Proceed Right. Les RSU détenues par le déclarant ont été annulées en échange de la contrepartie par action ; les RSU non acquises restent néanmoins soumises aux conditions de vesting originales liées à la poursuite du service.

Manmohan Mahajan, EVP und Global CFO von Walgreens Boots Alliance (WBA), meldete eine Transaktion vom 28.08.2025, bei der er 414.273 Aktien der WBA-Stammaktien veräußerte und nach der Transaktion 0 Aktien besitzt. Im Formular 4 wird erläutert, dass die Veräußerung aus der Verschmelzung gemäß dem Fusionsvertrag vom 6. März 2025 resultierte: Zum Zeitpunkt des Wirksamwerdens wurde jede Aktie in $11,45 in bar zuzüglich eines Divested Asset Proceed Right umgewandelt. Die vom Meldenden gehaltenen RSUs wurden im Austausch gegen die Vergütung pro Aktie annulliert; nicht unverfallte RSUs unterliegen weiterhin den ursprünglichen Vesting-Bedingungen, die an die fortgesetzte Dienstzeit geknüpft sind.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mahajan Manmohan

(Last) (First) (Middle)
C/O WALGREENS BOOTS ALLIANCE, INC.
108 WILMOT ROAD

(Street)
DEERFIELD IL 60015

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Walgreens Boots Alliance, Inc. [ WBA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and Global CFO
3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/28/2025 D 414,273(1) D (2)(3)(4) 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Includes shares underlying restricted stock units ("RSUs"), inclusive of RSUs issued in lieu of dividends.
2. Pursuant to the Agreement and Plan of Merger, dated as of March 6, 2025 (the "Merger Agreement"), by and among Walgreens Boots Alliance, Inc., a Delaware corporation (the "Company"), Blazing Star Parent, LLC, a Delaware limited liability company ("Parent"), Blazing Star Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), and the other affiliates of Parent named therein, Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent.
3. At the effective time of the Merger (the "Effective Time") each share of Common Stock was automatically converted into the right to receive from Parent (i) $11.45 in cash, without interest thereon and subject to all applicable withholding (the "Per Share Cash Consideration"), and (ii) one divested asset proceed right issued by Parent or one of its affiliates subject to and in accordance with the divested asset proceed rights agreement (each, a "Divested Asset Proceed Right" and, collectively with the Per Share Cash Consideration, the "Per Share Consideration").
4. Pursuant to the Merger Agreement, each RSU owned by the reporting person at the Effective Time was cancelled in exchange for the Per Share Consideration, provided that, payment of such consideration with respect to any RSUs that were unvested as of the Effective Time will remain subject to the Reporting Person's continued service as an employee, consistent with the vesting conditions applicable to such RSU immediately prior to the Effective Time.
/s/ Manmohan Mahajan by Cherita Thomas, Attorney-in-Fact 08/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for WBA and what is their role?

The Form 4 was filed by Manmohan Mahajan, who is EVP and Global CFO of Walgreens Boots Alliance.

What transaction occurred on 08/28/2025 for WBA?

On 08/28/2025 the reporting person disposed of 414,273 shares of WBA common stock as part of the merger conversion.

What did each WBA share convert into under the Merger Agreement?

Each share converted into $11.45 in cash plus one Divested Asset Proceed Right from Parent or its affiliate.

How were restricted stock units (RSUs) treated in the merger?

Each RSU was cancelled in exchange for the Per Share Consideration; any unvested RSUs remain subject to continued service per original vesting conditions.

What is the reporting person’s beneficial ownership after the transaction?

The reporting person beneficially owned 0 shares following the reported transaction.
Walgreen Boots

NASDAQ:WBA

WBA Rankings

WBA Latest News

WBA Latest SEC Filings

WBA Stock Data

10.37B
710.98M
17.44%
60.94%
2.67%
Pharmaceutical Retailers
Retail-drug Stores and Proprietary Stores
Link
United States
DEERFIELD